Breaking News, Promotions & Moves

Aktis Oncology Appoints Kyle Kuvalanka Chief Financial Officer

Kuvalanka brings over 20 years of experience in biopharmaceutical leadership, including finance, business development, and corporate strategy.

By: Rachel Klemovitch

Assistant Editor

Aktis Oncology, Inc., a clinical-stage oncology company focused on targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, appointed Kyle Kuvalanka as Chief Financial Officer (CFO). The appointment strengthens Aktis’ financial and corporate development leadership as the company advances its clinical pipeline and corporate growth initiatives. Kuvalanka brings over 20 years of substantial senior leadership experience in the biopharmaceutical ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters